INTRODUCTION
The immune response to herpes simplex virus type 1 (HSV-1) is largely directed against the structural glycoproteins of the virus which are present in the virion envelope and on the surface of infected ceils (for review see Norrild, 1985) . The importance of the individual glycoproteins in eliciting specific immune responses were initially studied using immunopurified antigens (Chart et al., 1985) and with virus mutants deficient in the expression of certain glycoproteins (Glorioso et al., 1985) . More recently, vaccinia virus recombinants (Cremer et al., 1985; McLaughlin-Taylor et al., 1988 ; Sullivan & Smith, 1987 and eukaryotic cell lines (Blacklaws et al., 1987; Rosenthal et al., 1987) expressing individual glycoprotein genes have begun to play a prominent role in the definition of the immune response to individual glycoproteins. Of the seven glycoproteins identified so far in HSV-1 (gB, gC, gD, gE, gG, gH and gI), glycoprotein D (gD) appears to be a dominant antigen in the immune response, as well as being an essential protein for viral infectivity (Blacklaws et al., 1987; Gompels & Minson, 1986; Rosenthal et al., 1987;  for review see Marsden, 1987) .
Among the structural glycoproteins, against all of which antibodies have been generated, gD is capable of eliciting high titre neutralizing antibody (for review see Marsden, 1987) . Glycoprotein D also elicits delayed-type hypersensitivity (DTH) responses and class IIrestricted T cell proliferative responses as measured by thymidine incorporation assays, but so far no major histocompatibility complex (MHC) class I-linked T cell responses have been detected (Blacklaws et al., 1987; . Despite these observations there is still a lack of understanding of the mechanisms of protection. Since gD is likely to form an important component of any subunit vaccine we wished to explore further the mechanisms of protection and to define antigenic regions recognized by the immune system. The antigenic regions recognized by neutralizing antibodies have been identified by raising monoclonal antibodies (MAbs) against gD and by identifying amino acid substitutions that confer resistance to neutralization. This enables oligopeptides to be synthesized on the basis of the probable antigenic regions deduced from the primary amino acid sequence (Eisenberg et al., 1982 (Eisenberg et al., , 1985 Cohen et al., 1986 ). Our interest is in the nature of class II-restricted T cell responses (for review see Nash et al., 1985) and we wish to identify the antigenic regions or T cell-recognized epitopes on gD, and so sought an expression system that would fulfil the dual role of stimulating specific immune responses to gD and offer a large enough source of protein for purification. The latter would allow peptides to be generated by enzymic or chemical cleavage and thereby enable T cell epitopes to be defined.
The high levels of expression of foreign proteins under the polyhedrin gene promoter (for review see Luckow & Summers, 1988 ) of the baculovirus expression vector prompted us to examine the expression and immunogenicity of HSV-1 gD in this system. Recombinant baculoviruses are increasingly being used to generate large quantities of viral proteins. For example, the parainfluenza virus type 3 haemagglutinin-neuraminidase has been expressed in a baculovirus recombinant (Coelingh et al., 1987) In this paper we report on the generation of two baculovirus recombinants expressing gD and the subsequent immune responses generated following immunization with extracts of cells infected by these recombinants. We have also explored the use of the extracts to generate proliferative responses in vitro from draining lymph node cells of HSV-l-infected mice.
METHODS
Mice. Female CBA mice 8 to 12 weeks of age were obtained from the Department of Pathology Animal House, University of Cambridge, U.K.
Viruses. HSV-1 strain SC16 was grown and titrated on BHK-21 cells and stored at -70 °C. The wild-type Autogrupha californica nuclear polyhedrosis virus (AcNPV) and the recombinant baculoviruses AeNgD-a and AcNgD-b were grown in Spodopterafrugiperda cells (Sf21) at 28 °C in TC100 medium supplemented with 10~o foetal calf serum and antibiotics. Viral supernatants were harvested after 3 to 4 days and working stocks were incubated at 4 °C. Virus stocks were assayed on S. frugiperda monolayers as described by Brown & Faulkner (1987) .
Subcloning of the gD gene into the transfer plasmid. An HSV-I BamHI fragment J clone (strain Patton) (Watson et al., 1982) in pBR322 (a gift from R. Watson, Minneapolis, Mn., U.S.A.) was double-digested with HindlII and NruI and the 1.4 kb (Fig. 1 b) fragment containing the coding sequences was isolated. This fragment was subcloned into the BamHI site of pAcYM1 ( Fig. la) and a plasmid, pAcYM-gD16, containing the gD gene in the correct orientation was isolated. The orientation was determined using standard restriction enzyme mapping, Southern blotting and hybridization techniques.
Recombinant virus construction, pAcYM-gD16 was used to generate two baculovirus recombinants, AcNgD-a and AcNgD-b, as in Overton et aL (1987) . Briefly, Sf21 cells were transfected with a mixture of I gtg AcNPV DNA and 25 to 100 p.g of plasmid pAcYM-gD 16 in the transfection buffer (0.125 M-calcium chloride in the presence of 20 mM-HEPES buffer pH 7.5 1 mM-disodium hydrogen orthophosphate, 5 ram-potassium chloride, 140 mMsodium chloride and 10 mM-glucose; total volume, 1 ml). The DNA suspension was inoculated onto a monolayer of 106 Sf21 cells in a 35 mm tissue culture dish, allowed to absorb on the cells for 1 h at room temperature and then replaced with 1.5 ml of medium. After incubation at 28 °C for 2 days the supernatant fluids were harvested and used to produce plaques in S. frugiperda cell monolayers. Plaques containing recombinant virus were identified by the lack of polyhedra when examined by light microscopy and were then plaque-purified.
Preparation ofbaculovirus-infected cell extracts. Confluent sheets of Sf21 cells were infected at an m.o.i, of 1 and incubated for 3 to 4 days. Following the detection of polyhedra in the wild-type virus-infected cells and clear c.p.e. in the baculovirus recombinant-infected cells, the cell monolayers were harvested. The infected cell extracts were used in lymphocyte stimulation assays and protection experiments. For the protection experiments, 5 x 106 cells (cell extracts/mouse) were injected subcutaneously (s.c.) in 20 gl or intraperitoneally (i.p.) in 0.5 ml of phosphatebuffered saline (PBS) and mice were reimmunized with the same dose 10 days later. After a further 7 days the mice were challenged with 5 x 10 • p.f.u. SC16 in 20 gl PBS in the left ear pinna, which was removed after 5 days and stored at -70 °C. The ears were homogenized in 1 ml Eagle's medium (Glasgow modification) with tryptose phosphate broth, plus 10% heat-inactivated foetal calf serum.
IP: 54.70.40.11
On: Wed, 24 Oct 2018 04:50:51 Immunoprecipitations. Monolayers of Sf21 cells were infected with AcNPV or with recombinant baculoviruses at an m.o.i, of 10 and incubated at 28 °C for 48 h. The cells were then incubated in methionine-free medium for 1.5 h and subsequently labelled for 2 h with 50 ~tCi of [35S]methionine in 0.7 ml of methionine-free medium Blacklaws et aL, 1987) . For the N-linked glycosylation inhibition experiments, tunicamycin was added at 5 lag/ml in the methionine-free medium for both the starvation and labelling periods. For the preparation of radiolabelled cell extracts of HSV-1, confluent layers of BHK cells were infected at an m.o.i, of 10, and 4 h after infection the cells were incubated for 20 h in 0.7 ml methionine-free medium with 50 ~tCi of [35S]methionine. Following three washes in cold PBS the cells were lysed in 1 ml radioimmunoprecipitation assay (RIPA) buffer (50 mM-Tris-HCl pH 7-2, 150 mM-NaCI, 1 ~ sodium deoxycholate, 0.1 ~ SDS, 1 ~o Triton X-100) with 2 mM-PMSF and 10 units of micrococcal DNase per ml. Lysates were clarified by centrifugation at 100000 g for 1 h at 4 °C. Immunoprecipitations were performed on 250 p.l of lysates with 30 p.1 of the mixture of MAbs (i.e. 10 ~tl of LP2, LP3 and LP14 respectively; gifts of A. Minson, Cambridge, U.K.). All samples were boiled for 3 rain before use. Samples of 20 p.l were electrophoresed for 4 h at 35 mA on 12.5 ~ acrylamide-0.1 ~ N,N'-methylenebisacryalamide resolving gels with 3~ acrylamide4).13~ N,N'-methylenebisacryalamide stacking gels using the SDS buffer system of Laemmli (1970) . The gels were then fixed, tluorographed (Bonner & Laskey, 1974) and dried before exposure to Kodak X-Omat S film at -70 °C.
Recognition of HSV-1 gD in an AcNPV recombinant
Immunoblots. BHK cells infected with HSV-I at an m.o.i, of 10 or mock-infected were harvested after 20 h. Sf21 ceils were infected with either the baculovirus recombinant or the wild-type AcNPV and incubated at 28 °C for 48 h. The cells were suspended in 100 ~tl of Laemmli buffer and boiled for 3 min. Ten Ixl of the samples was electrophoresed in the conditions described above, under the section on immunoprecipitation. Proteins within the gel were transferred onto nitrocellulose filters by electrophoresis in transfer buffer (25 mM-Tris, 186 mM-glycine and 20~ methanol) at 200 mA for 4 h. The nitrocellulose filters were washed in distilled water and then incubated in blocking buffer for 2 h (25 mM-Tris-HC1 pH 7-8, 2 mM-calcium chloride, 5~ w/v non-fat dried milk, 0.05~ Triton X-100) at room temperature. The blots were then incubated with the appropriate dilutions of the antibodies in PBS for 2 h. Following three quick washes with the blocking buffer, the filters were incubated with a 1000-fold dilution of anti-mouse immunoglobulin (peroxidase-conjugated rabbit immunoglobulin; Dako). The blots were developed with dichloronaphthol. Lymphocyte stimulation assays. The assay for measuring lymphocyte proliferation was as described by Nash et al. 
R E S U L T S

Identification and characterization of glycoprotein D produced by the baculovirus recombinants
The two recombinants were analysed for the expression of gD using a mixture of MAbs against gD. To characterize the gD polypeptides produced in Sf21 cells infected with AcNgD-b, [35S]methionine-labelled cell lysates were treated with these MAbs which precipitated two polypeptides with an Mr of approx. 48K (Fig. 2, lane 4) Lysates of ceils infected with AcNgD-b, AcNgD-a and AcNPV (lanes 1, 2 and 3) were also electrophoresed on a 12-5~ polyacrylamide gel and transferred to nitrocellulose filters, Filters were reacted with sera from HSV-l-infected mice (diluted 50-fold).
detected in the AcNPV-infected cell extracts (Fig. 2, lane 5) . In the presence of tunicamycin one of the bands was no longer visible and the other was markedly diminished in intensity (Fig. 2 , lane l) with no other detectable polypeptides. For comparison the gD polypeptides in HSV-1-infected BHK cells were immunoprecipitated following a 20 h labelling (Fig. 2, lane 6) . The predominant polypeptide detected was a 58K polypeptide. With tunicamycin, the final mature form was underproduced and the major polypeptide visible was a 48K protein (Fig. 2, lane 3) . The 48K band is likely to be the partially glycosylated polypeptide with O-linked sugar residues. No bands were visible in the mock-infected BHK cell preparations (data not shown). The presence of polypeptides corresponding to gD was demonstrated by using MAbs against gD on Western blots of the baculovirus-infected cell extracts. In the AcNgD-a-and AcNgD-binfected extracts, the MAbs identified a 48K polypeptide (Fig. 3 a, lanes 1 and 2) which was clearly not detected in the AcNPV-infected cells (Fig. 3a, lane 3) . Sera from H-2k mice infected with HSV-1 identified a similar band in both these recombinant-infected extracts on Western blots (Fig. 3 b, lanes 1 and 2) and this was not detected in the AcNPV-infected cell extracts (Fig.  3 b, lane 3) . Preimmune sera from H-2k mice detected no bands on Western blots of AcNgD-a-, AcNgD-b-and AeNPV-infected cell extracts (data not shown). In Coomassie Brilliant Bluestained gels the polyhedrin protein was detected in the AcNPV-infected cells but not in those infected by the baculovirus recombinants (data not shown). However, in the same gels the multiplicity of bands in the 48K region made positive identification of gD in these cell extracts difficult. 4. 49, 4-14, 4.00, 3.60, 3.44 3.31, 3-17, 3.14, 3 .07, 2.55 <1, <1, <1, <1, <1 <1, <1, <1, <1, <1 * CBA mice were injected i.p. or s.c. with extracts of AcNgD-b-infected cells and re-immunized by the same route after 10 days (see Methods) and challenged with 5 x 104 p.f.u. SC16 in the left ear pinna 7 days later. Ears were removed 5 days later and infective virus titres were determined by a plaque assay. Each result is derived from an ear from one mouse.
Immunization of mice with baculovirus recombinants
CBA mice (six per group) were immunized either i.p. or s.c. (see Methods). Table 1 displays the viral titres 5 days after an HSV-1 challenge. Mice immunized either way with AcNgD-b were protected against subsequent challenge. The AcNPV-infected group showed a reduction in viral titre of about 1 loglo p.f.u, compared to the non-infected control group, probably due to the activation of non-specific mechanisms aiding viral clearance.
Generation of gD-specific antibody
Mice were bled after two immunizations with AcNgD-b cell extracts and the sera pooled from five mice were used to detect the presence of neutralizing antibody. In the complementdependent assay anti-AcNgD-b sera neutralized HSV-1 infectivity considerably, with 90~o neutralization obtained in a 256-fold dilution and 50~ neutralization at > 1:1000 dilution (Fig.  4a) . In the complement-independent assay, the 50~ neutralizing point was > 1:256 dilution (Fig. 4b) . There was no reduction in plaque numbers with undiluted anti-AcNPV sera. On Western blots of HSV-1-infected cell extracts, sera from the AcNgD-b-infected mice identified a 58K band corresponding to gD (Fig. 5, lane 3) . On the same blot this protein was identified by the MAb LP14 (lane 1) and sera from mice infected with MDK, a thymidine kinase-deficient mutant of HSV-1 (lane 4). No corresponding band was identified with sera from mice infected with AcNPV (lane 2). 
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T cell recognition of AcNgD cell-infected extracts
To investigate the recognition ofgD in the AcNgD-infected cell extracts by T cells from HSV-1-infected mice, draining lymph node cells obtained from HSV-l-infected CBA mice were studied in lymphocyte stimulation assays. The lymph node cells proliferated in response to AcNgD-infected cell extracts in vitro. Table 2 demonstrates the specific proliferation response to HSV-1-and AcNgD-infected cell extracts as measured by tritiated thymidine incorporation over 24 h after a 4 day culture, compared to the responses to mock-infected and AcNPV-infected cell extracts.
DISCUSSION
In this report we demonstrate the expression of gD of HSV-1 by recombinant baculoviruses and the immunogenicity of this protein in mice. Immunoprecipitation of [35S]methionine-labelled infected cell extracts and Western blots have identified 48K polypeptides in baculovirus recombinant-infected cells compared with a 58K gD protein expressed following HSV-1-infection of mammalian cells. According t o the results of tunicamycin inhibition experiments, the polypeptide produced in the AcNgD-b recombinant undergoes N-linked glycosylation. The 2 h [3SS]methionine labelling with tunicamycin inhibition was done 48 h after infection and demonstrated underproduction of the 48K polypeptides with no detectable precursor polypeptides. Further studies on this recombinant and a better understanding of glycosylation in insect ceils should provide a clearer picture of the glycosylation and processing of gD in AcNgD-b infections. Similar processing has been observed with the influenza virus haemagglutinin (Kuroda et al., 1986; Possee, 1986) produced in insect cells by baculovirus recombinants, where the Mr of the protein is less than that expressed in mammalian cells. However, the antigenic and biological properties of haemagglutinin remain unaltered. Studies with baculovirus recombinants have suggested that in insect ceils although N-linked glycosylation does occur (for review see Luckow & Summers, 1988 ) the subsequent addition and processing of complex residues are different.
Aside from the differences in the Mr of gD expressed by insect cells, gD expressed by baculoviruses is clearly a protein which is highly immunogenic, confirming earlier observations on its immunogenicity in other expression systems (Blacklaws et al., 1987; . A strong neutralizing antibody response is generated following immunization with cell extracts of AcNgD-b. In our experience, this is the highest titre of neutralizing antibody that has so far been generated against gD. It is likely that this antibody response is a major factor in protection against subsequent HSV challenges. Neutralizing antibodies are clearly an important effector mechanism against HSV-1 and MAbs against gD transfer passive immunity (Simmons & Nash, 1985) .
It is likely that the amount of gD produced by any particular expression vector determines the titre of the neutralizing antibody generated. Our immunoblot and immunoprecipitation results suggest that the baculovirus recombinants express more gD than either vaccinia virus recombinants or cell lines constitutively expressing gD. But we have not yet been able to make a definite estimate of the levels of expression in the baculovirus recombinants. We have attempted to quantify the amount ofgD expressed by these vectors on Coomassie Brilliant Bluestained polyacrylamide gels, since the multiplicity of bands at the 48K region has made quantification difficult. Experiments are under way using fluorescence-activated cell sorter analysis to make a comparison of the amount of gD constitutively expressed in eukaryotic cell lines, by vaccinia-gD recombinants and by baculovirus recombinants expressing gD.
We have also demonstated recognition of gD in the baculovirus recombinant-infected cell extracts by T cells from draining lymph node cells of HSV-l-infected mice. The different glycosylation pattern of gD produced in these extracts does not appear to hinder the recognition by T cells from HSV-1-infected mice. This is in keeping with the current understanding of T cell recognition that the primary amino acid sequence is most important and that secondary modifications of the protein do not unduly influence the binding of the peptide fragments to the MHC glycoproteins. Consequently, proteins derived from baculovirus recombinants can be purified and used to define the epitopes T cells recognize.
Mice immunized with AcNgD-infected cell extracts are highly efficient in resisting subsequent HSV-1 challenges (5 x 104 p.f.u.). These results compare with clearance of virus by mice immunized with vaccinia virus recombinants and from cells expressing gD. Using vaccinia virus recombinants expressing gD, and suggested that although the vector elicited a protective response, the extent of this immunity was less than that which occurred following immunization with HSV-1. They based their conclusions on the observations that whereas immunization with the recombinants protected against a challenge of only 104 TCIDso, mice immunized with HSV-1 protected against higher challenge doses. They suggested that this difference was attributable to the failure of gD to generate cytotoxic T lymphocytes. Since the baculovirus recombinants express more gD it would be important to check whether this defect can be overcome by immunizations with gD.
Glycoprotein D has been suggested as a component for a possible subunit vaccine. With the recent approval of a human immunodeficiency virus glycoprotein (Luckow & Summers, 1988) expressed by a baculovirus as a vaccine against infections, the possibility of using the gD recombinants as a vaccine for HSV infection remains a distinct possibility. The above experiments suggest that AcNgD confers strong immunity against subsequent HSV-1 infections.
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